Skip to main content
. Author manuscript; available in PMC: 2016 Aug 24.
Published in final edited form as: Breast J. 2015 Aug 14;21(5):514–519. doi: 10.1111/tbj.12445

Table 4.

Qualitative Analysis of Role of Oncotype Dx in Treatment Planning

Low risk Oncotype DX score
Intermediate risk Oncotype DX score
CR (n = 15) NO CR (n = 70) CR (n = 26) NO CR (n = 22)
Some role 7 (47%) 57 (81%) 18 (69%) 16 (73%)
No role 6 (40%) 6 (9%) 4 (14.5%) 2 (9%)
Role unclear 2 (13%) 7 (10%) 4 (14.5%) 4 (18%)